Tag: grants

Research Grants Council to present public lecture on Happy, Healthy, Longevity – AI Can Help on January 20 ****************************************************************************************** The following is issued on behalf of the University Grants Committee:        In line with the Government’s initiative to promote STEAM (Science, Technology, Engineering, the Arts and Mathematics) education for all, for fun and for diversity, the Research Grants Council (RGC) is organising a series of public lectures titled Happy, Healthy, Longevity – AI Can Help, covering areas including technology, innovation and health. The second lecture of the series will be held at the Hong Kong Science Museum on ... Read more

Eisai Co., Ltd. and Biogen Inc. announced today that the U.S. Food and Drug Administration (FDA) has approved the supplemental Biologics License Application (sBLA) supporting the traditional approval of LEQEMBI (lecanemab-irmb) 100 mg/mL injection for intravenous use, making LEQEMBI the first and only approved treatment shown to reduce the rate of disease progression and to slow cognitive and functional decline in adults with Alzheimer’s disease (AD). LEQEMBI demonstrated clinically meaningful slowing of cognitive and functional decline in a patient group generalizable to U.S. Medicare beneficiaries, which included a mix of racial and ethnic groups, patients with common comorbid conditions, concomitant ... Read more

NTT DOCOMO, INC. announced today that it has reached an agreement to grant a patent license covering DOCOMO’s standard essential patents(1) including 5G to Samsung Electronics Co., Ltd. As part of the agreement, Samsung is to pay licensing fees to DOCOMO. DOCOMO has been actively involved in the research and development of mobile network related technologies such as W-CDMA, LTE, LTE-Advanced, 5G and 6G, and new service-related technologies, to realize its ultimate goal of enhancing mobile experiences for customers. DOCOMO has also been applying for patents on these technologies, resulting in its ownership of some 10,000 standard essential patents for ... Read more

NTT DOCOMO, INC. announced today that it has reached an agreement to grant a patent license covering cellular wireless standard essential patents(1) including 5G to electronics manufacturer Lenovo. DOCOMO has been actively involved in the research and development of mobile network related technologies such as W-CDMA, LTE, LTE-Advanced, 5G and 6G, and new service-related technologies, to realize its ultimate goal of enhancing mobile experiences for customers. DOCOMO has also been applying for patents on these technologies, resulting in its ownership of some 10,000 standard essential patents for mobile communications(2). In turn, DOCOMO has licensed its cellular wireless standard essential patents ... Read more

Eisai Co., Ltd. and Biogen Inc. announced today that the U.S. Food and Drug Administration (FDA) has accepted the Biologics License Application (BLA) under the accelerated approval pathway for lecanemab (development code: BAN2401), an investigational anti-amyloid beta (Abeta) protofibril antibody for the treatment of mild cognitive impairment (MCI) due to Alzheimer’s disease (AD) and mild AD (collectively known as early AD) with confirmed presence of amyloid pathology in the brain. Eisai’s application, which was completed in early May 2022, has been granted Priority Review, with a Prescription Drug User Fee Act (PDUFA) action date of January 6, 2023. “Alzheimer’s disease ... Read more